29 research outputs found

    Financial impact of reducing door-to-balloon time in ST-elevation myocardial infarction: a single hospital experience

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The impact of reducing door-to-balloon time on hospital revenues, costs, and net income is unknown.</p> <p>Methods</p> <p>We prospectively determined the impact on hospital finances of (1) emergency department physician activation of the catheterization lab and (2) immediate transfer of the patient to an immediately available catheterization lab by an in-house transfer team consisting of an emergency department nurse, a critical care unit nurse, and a chest pain unit nurse. We collected financial data for 52 consecutive ST-elevation myocardial infarction patients undergoing emergency percutaneous intervention from October 1, 2004–August 31, 2005 and compared this group to 80 consecutive ST-elevation myocardial infarction patients from September 1, 2005–June 26, 2006 after protocol implementation.</p> <p>Results</p> <p>Per hospital admission, insurance payments (hospital revenue) decreased (35,043±35,043 ± 36,670 vs. 25,329±25,329 ± 16,185, P = 0.039) along with total hospital costs (28,082±28,082 ± 31,453 vs. 18,195±18,195 ± 9,242, P = 0.009). Hospital net income per admission was unchanged (6962vs.6962 vs. 7134, P = 0.95) as the drop in hospital revenue equaled the drop in costs. For every 1000reductionintotalhospitalcosts,insurancepayments(hospitalrevenue)dropped1000 reduction in total hospital costs, insurance payments (hospital revenue) dropped 1077 for private payers and 1199forMedicare/Medicaid.Adecreaseinhospitalcharges(1199 for Medicare/Medicaid. A decrease in hospital charges (70,430 ± 74,033vs.74,033 vs. 53,514 ± 23,378,P=0.059),diagnosisrelatedgrouprelativeweight(3.7479±2.6731vs.2.9729±0.8545,P=0.017)andoutlierpaymentswithhospitalrevenue>23,378, P = 0.059), diagnosis related group relative weight (3.7479 ± 2.6731 vs. 2.9729 ± 0.8545, P = 0.017) and outlier payments with hospital revenue>100,000 (7.7% vs. 0%, P = 0.022) all contributed to decreasing ST-elevation myocardial infarction hospitalization revenue. One-year post-discharge financial follow-up revealed similar results: Insurance payments: 49,959±49,959 ± 53,741 vs. 35,937±35,937 ± 23,125, P = 0.044; Total hospital costs: 39,974±39,974 ± 37,434 vs. 26,778±26,778 ± 15,561, P = 0.007; Net Income: 9984vs.9984 vs. 9159, P = 0.855.</p> <p>Conclusion</p> <p>All of the financial benefits of reducing door-to-balloon time in ST-elevation myocardial infarction go to payers both during initial hospitalization and after one-year follow-up.</p> <p>Trial Registration</p> <p><b>ClinicalTrials.gov ID</b>: NCT00800163</p

    Current clinical applications of spectral tissue Doppler echocardiography (E/E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function

    Get PDF
    Congestive heart failure with preserved left ventricular systolic function has emerged as a growing epidemic medical syndrome in developed countries, which is characterized by high morbidity and mortality rates. Rapid and accurate diagnosis of this condition is essential for optimizing the therapeutic management. The diagnosis of congestive heart failure is challenging in patients presenting without obvious left ventricular systolic dysfunction and additional diagnostic information is most commonly required in this setting. Comprehensive Doppler echocardiography is the single most useful diagnostic test recommended by the ESC and ACC/AHA guidelines for assessing left ventricular ejection fraction and cardiac abnormalities in patients with suspected congestive heart failure, and non-invasively determined basal or exercise-induced pulmonary capillary hypertension is likely to become a hallmark of congestive heart failure in symptomatic patients with preserved left ventricular systolic function. The present review will focus on the current clinical applications of spectral tissue Doppler echocardiography used as a reliable noninvasive surrogate for left ventricular diastolic pressures at rest as well as during exercise in the diagnosis of heart failure with preserved left ventricular systolic function. Chronic congestive heart failure, a disease of exercise, and acute heart failure syndromes are characterized by specific pathophysiologic and diagnostic issues, and these two clinical presentations will be discussed separately
    corecore